Ustekinumab for treating moderately to severely active CD after prior therapy

Robert Hodgson, Mousumi Biswas, Teumzghi Mebrahtu, Matthew James Walton, Melissa Harden, Nerys Frances Woolacott*

*Corresponding author for this work

Research output: Book/ReportCommissioned report

Original languageEnglish
PublisherNational Institute for Health and Care Excellence
Commissioning bodyNational Institute for Health and Care Excellence
Publication statusPublished - 12 Jul 2017

Cite this